Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32-35 weeks' gestational age with more informed use of risk factors?

about

The Role of Human Milk Immunomodulators in Protecting Against Viral Bronchiolitis and Development of Chronic Wheezing Illness.Cost-effectiveness of palivizumab compared to no prophylaxis in term infants residing in the Canadian Arctic.

P2860

Q38897076-B5A96FA0-C191-4544-AE79-554921B0DC84 Q40227824-13C698CC-7F4B-4961-AE19-E58BA069E25E

P2860

Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32-35 weeks' gestational age with more informed use of risk factors?

Item

http://www.wikidata.org/entity/Q42204657

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Can we improve the targeting o ...... informed use of risk factors?

@en

Can we improve the targeting of respiratory syncytial virus

@nl

type

Item

label

Can we improve the targeting o ...... informed use of risk factors?

@en

Can we improve the targeting of respiratory syncytial virus

@nl

prefLabel

Can we improve the targeting o ...... informed use of risk factors?

@en

Can we improve the targeting of respiratory syncytial virus

@nl

P1476

Can we improve the targeting o ...... informed use of risk factors?

@en

P2093

Barry S Rodgers-Gray

http://www.w3.org/2001/XMLSchema#string

John R Fullarton

http://www.w3.org/2001/XMLSchema#string

Jose Figueras-Aloy

http://www.w3.org/2001/XMLSchema#string

Katherine L Gooch

http://www.w3.org/2001/XMLSchema#string

Pamela G Vo

http://www.w3.org/2001/XMLSchema#string

Xavier Carbonell-Estrany

http://www.w3.org/2001/XMLSchema#string

P2860

The use of multiple measurements in taxonomic problems

The number needed to treat: a clinically useful measure of treatment effect

A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study.

European risk factors' model to predict hospitalization of premature infants born 33-35 weeks' gestational age with respiratory syncytial virus: validation with Italian data.

Immunoprophylaxis of respiratory syncytial virus: global experience.

The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation.

Calibration and discrimination by daily Logistic Organ Dysfunction scoring comparatively with daily Sequential Organ Failure Assessment scoring for predicting hospital mortality in critically ill patients.

Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.

Using numerical results from systematic reviews in clinical practice.

Rehospitalization for respiratory syncytial virus among premature infants.

P304

1133-1141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/14767058.2014.947573

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25048748

http://www.w3.org/2001/XMLSchema#string

Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32-35 weeks' gestational age with more informed use of risk factors?

about

P2860

P2860

Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32-35 weeks' gestational age with more informed use of risk factors?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698